Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066

Watchlist Manager
Shandong Weigao Group Medical Polymer Co Ltd Logo
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Watchlist
Price: 5.52 HKD -1.25% Market Closed
Market Cap: 25.1B HKD

Intrinsic Value

The intrinsic value of one Shandong Weigao Group Medical Polymer Co Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 5.52 HKD, Shandong Weigao Group Medical Polymer Co Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Shandong Weigao Group Medical Polymer Co Ltd Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Shandong Weigao Group Medical Polymer Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Shandong Weigao Group Medical Polymer Co Ltd looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if Shandong Weigao Group Medical Polymer Co Ltd is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Shandong Weigao Group Medical Polymer Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Shandong Weigao Group Medical Polymer Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Shandong Weigao Group Medical Polymer Co Ltd.

Explain Valuation
Compare Shandong Weigao Group Medical Polymer Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Shandong Weigao Group Medical Polymer Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Shandong Weigao Group Medical Polymer Co Ltd

Current Assets 20.7B
Cash & Short-Term Investments 9.7B
Receivables 8.4B
Other Current Assets 2.6B
Non-Current Assets 15.4B
Long-Term Investments 2.2B
PP&E 7.5B
Intangibles 5B
Other Non-Current Assets 781.7m
Current Liabilities 5.6B
Accounts Payable 4.2B
Other Current Liabilities 1.4B
Non-Current Liabilities 6.5B
Long-Term Debt 4.6B
Other Non-Current Liabilities 1.9B
Efficiency

Free Cash Flow Analysis
Shandong Weigao Group Medical Polymer Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Shandong Weigao Group Medical Polymer Co Ltd

Revenue
13.1B CNY
Cost of Revenue
-6.6B CNY
Gross Profit
6.5B CNY
Operating Expenses
-3.9B CNY
Operating Income
2.6B CNY
Other Expenses
-613.6m CNY
Net Income
2B CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Shandong Weigao Group Medical Polymer Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Healthy Gross Margin
Strong 3Y Average Gross Margin
Healthy Operating Margin
Sustainable 3Y Average Operating Margin
hidden
Profitability
Score

Shandong Weigao Group Medical Polymer Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Shandong Weigao Group Medical Polymer Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Negative Net Debt
hidden
Solvency
Score

Shandong Weigao Group Medical Polymer Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Shandong Weigao Group Medical Polymer Co Ltd

Wall Street analysts forecast Shandong Weigao Group Medical Polymer Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shandong Weigao Group Medical Polymer Co Ltd is 6.99 HKD with a low forecast of 5.25 HKD and a high forecast of 8.61 HKD.

Lowest
Price Target
5.25 HKD
5% Downside
Average
Price Target
6.99 HKD
27% Upside
Highest
Price Target
8.61 HKD
56% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Shandong Weigao Group Medical Polymer Co Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Shandong Weigao Group Medical Polymer Co Ltd stock?

The intrinsic value of one Shandong Weigao Group Medical Polymer Co Ltd stock under the Base Case scenario is hidden HKD.

Is Shandong Weigao Group Medical Polymer Co Ltd stock undervalued or overvalued?

Compared to the current market price of 5.52 HKD, Shandong Weigao Group Medical Polymer Co Ltd is hidden .

Back to Top